Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human
- PMID: 29622147
- PMCID: PMC6309616
- DOI: 10.1016/j.jcin.2018.01.247
Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human
Abstract
Objectives: This study sought to develop a novel technique called bioprosthetic or native aortic scallop intentional laceration to prevent coronary artery obstruction (BASILICA).
Background: Coronary artery obstruction is a rare but fatal complication of transcatheter aortic valve replacement (TAVR).
Methods: We lacerated pericardial leaflets in vitro using catheter electrosurgery, and tested leaflet splaying after benchtop TAVR. The procedure was tested in swine. BASILICA was then offered to patients at high risk of coronary obstruction from TAVR and ineligible for surgical aortic valve replacement. BASILICA used marketed devices. Catheters directed an electrified guidewire to traverse and lacerate the aortic leaflet down the center line. TAVR was performed as usual.
Results: TAVR splayed lacerated bovine pericardial leaflets. BASILICA was successful in pigs, both to left and right cusps. Necropsy revealed full length lacerations with no collateral thermal injury. Seven patients underwent BASILICA on a compassionate basis. Six had failed bioprosthetic valves, both stented and stent-less. Two had severe aortic stenosis, including 1 patient with native disease, 3 had severe aortic regurgitation, and 2 had mixed aortic valve disease. One patient required laceration of both left and right coronary cusps. There was no hemodynamic compromise in any patient following BASILICA. All patients had successful TAVR, with no coronary obstruction, stroke, or any major complications. All patients survived to 30 days.
Conclusions: BASILICA may durably prevent coronary obstruction from TAVR. The procedure was successful across a range of presentations, and requires further evaluation in a prospective trial. Its role in treatment of degenerated TAVR devices remains untested.
Keywords: bioprosthetic heart valve failure; coronary artery obstruction; structural heart disease; transcatheter aortic valve replacement; transcatheter electrosurgery.
Published by Elsevier Inc.
Conflict of interest statement
Figures









Comment in
-
Tearing Down the Risk for Coronary Obstruction With Transcatheter Aortic Valve Replacement.JACC Cardiovasc Interv. 2018 Apr 9;11(7):690-692. doi: 10.1016/j.jcin.2018.01.266. JACC Cardiovasc Interv. 2018. PMID: 29622148 No abstract available.
References
-
- Leon MB, Smith CR, Mack MJ et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016;374:1609–20. - PubMed
-
- Reardon MJ, Van Mieghem NM, Popma JJ et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2017;376:1321–1331. - PubMed
-
- Dvir D, Webb JG, Bleiziffer S et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA : the journal of the American Medical Association 2014;312:162–70. - PubMed
-
- Webb JG, Mack MJ, White JM et al. Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. J Am Coll Cardiol 2017;69:2253–2262. - PubMed
-
- Ribeiro HB, Rodés-Cabau J, Blanke P et al. Incidence, Predictors and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Insights from the VIVID Registry [In Press]. Eur Heart J 2017. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical